Reuters logo
BRIEF-Radius Health initiates Phase 1 clinical trial of RAD140 for treatment of hormone receptor positive breast cancer
September 29, 2017 / 1:30 PM / 3 months ago

BRIEF-Radius Health initiates Phase 1 clinical trial of RAD140 for treatment of hormone receptor positive breast cancer

Sept 29 (Reuters) - Radius Health Inc

* Radius Health initiates Phase 1 clinical trial of RAD140 for the treatment of hormone receptor positive breast cancer

* Radius Health Inc - ‍clinical trial is designed to evaluate safety and maximum tolerated dose of RAD140 in approximately 40 patients​

* Radius Health Inc - pharmacokinetics, pharmacodynamics and tumor response will also be evaluated in Phase 1 trial​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below